ravulizumab
abagovomab
antistreptavidin
muromonab
-kin-
cergutuzumab
double-vaxxed
conatumumab
cross-reactivity
-toxa-
anti-nuclear factor
oleclumab
antinucleosome
elsilimomab
naptumomab estafenatox
autocentromere
serospecific
immunomodulant
cedelizumab
teneliximab
fontolizumab
drozitumab
immunosorbing
fluorescein isocyanate
heteroclitic
polyvalent
fluorescein isothiocyanate
otelixizumab
tocilizumab
talizumab
patritumab
sarilumab
antimonoclonal
zanolimumab
ozogamicin
antitoxin
antihaemolysin
polyantibody
precipitin
immunoprobe
mepolizumab
solitomab
sintilimab
vanucizumab
dinutuximab
retifanlimab
pozelimab
toripalimab
sasanlimab
zenocutuzumab